Author:
Barboza Andrés,Burgos Marcos,Cáceres Fernando,Carrá Adriana,Correale Jorge,Cristiano Edgardo,Patrucco Liliana,Piedrabuena Raúl,Rojas Juan I.,Sinay Vladimiro,Ysrraelit María Célica
Subject
Neurology (clinical),Neurology
Reference22 articles.
1. Aggressive multiple sclerosis (1): Towards a definition of the phenotype;Iacobaeus;Mult Scler.,2020
2. Highly active multiple sclerosis: An update;Díaz;Mult Scler Relat Disord.,2019
3. European Medicines Agency. Prospecto de cladribine [consultado Ago 2021]. Disponible en: https://www.ema.europa.eu/en/documents/product-information/mavenclad-epar-product-information_en.pdf
4. European Medicines Agency. Prospecto de alemtuzumab [consultado Ago 2021]. Disponible en: https://www.ema.europa.eu/en/documents/product-information/lemtrada-epar-product-information_en.pdf
5. European Medicines Agency. Prospecto de natalizumab [consultado Ago 2021]. Disponible en: https://www.ema.europa.eu/en/documents/product-information/tysabri-epar-product-information_en.pdf